TWI245605B - Method for producing nutritional product containing L-Arginine - Google Patents
Method for producing nutritional product containing L-Arginine Download PDFInfo
- Publication number
- TWI245605B TWI245605B TW92115715A TW92115715A TWI245605B TW I245605 B TWI245605 B TW I245605B TW 92115715 A TW92115715 A TW 92115715A TW 92115715 A TW92115715 A TW 92115715A TW I245605 B TWI245605 B TW I245605B
- Authority
- TW
- Taiwan
- Prior art keywords
- arginine
- granules
- ingredients
- ethanol
- mixing
- Prior art date
Links
- 229930064664 L-arginine Natural products 0.000 title claims abstract description 41
- 235000014852 L-arginine Nutrition 0.000 title claims abstract description 41
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 title claims abstract description 40
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 18
- 235000016709 nutrition Nutrition 0.000 title abstract 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 90
- 239000004615 ingredient Substances 0.000 claims abstract description 39
- 239000000047 product Substances 0.000 claims abstract description 37
- 239000008187 granular material Substances 0.000 claims abstract description 28
- 235000003599 food sweetener Nutrition 0.000 claims abstract description 20
- 239000003765 sweetening agent Substances 0.000 claims abstract description 20
- 235000015872 dietary supplement Nutrition 0.000 claims abstract description 19
- 239000000796 flavoring agent Substances 0.000 claims abstract description 17
- 238000005550 wet granulation Methods 0.000 claims abstract description 16
- 239000000314 lubricant Substances 0.000 claims abstract description 15
- 238000002156 mixing Methods 0.000 claims abstract description 15
- 238000001035 drying Methods 0.000 claims abstract description 14
- 235000019634 flavors Nutrition 0.000 claims abstract description 14
- 239000000945 filler Substances 0.000 claims abstract description 3
- 238000000034 method Methods 0.000 claims description 26
- 239000000203 mixture Substances 0.000 claims description 20
- 239000000049 pigment Substances 0.000 claims description 17
- 239000003795 chemical substances by application Substances 0.000 claims description 14
- 238000005469 granulation Methods 0.000 claims description 8
- 230000003179 granulation Effects 0.000 claims description 8
- 229940098465 tincture Drugs 0.000 claims description 8
- 238000004806 packaging method and process Methods 0.000 claims description 5
- -1 tinctures Substances 0.000 claims description 3
- 239000002304 perfume Substances 0.000 claims 1
- 238000007873 sieving Methods 0.000 claims 1
- 238000004040 coloring Methods 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 27
- 239000000843 powder Substances 0.000 description 15
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 9
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 9
- 235000013599 spices Nutrition 0.000 description 9
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 8
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 description 8
- 108010011485 Aspartame Proteins 0.000 description 8
- 239000000619 acesulfame-K Substances 0.000 description 8
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 8
- 239000000605 aspartame Substances 0.000 description 8
- 235000010357 aspartame Nutrition 0.000 description 8
- 229960003438 aspartame Drugs 0.000 description 8
- 235000013305 food Nutrition 0.000 description 8
- 239000001630 malic acid Substances 0.000 description 8
- 235000011090 malic acid Nutrition 0.000 description 8
- 229940099690 malic acid Drugs 0.000 description 8
- 239000002245 particle Substances 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 6
- 239000007968 orange flavor Substances 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 239000002075 main ingredient Substances 0.000 description 4
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 239000000811 xylitol Substances 0.000 description 4
- 235000010447 xylitol Nutrition 0.000 description 4
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 4
- 229960002675 xylitol Drugs 0.000 description 4
- PNEYBMLMFCGWSK-UHFFFAOYSA-N Alumina Chemical compound [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 229960004106 citric acid Drugs 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 238000011049 filling Methods 0.000 description 3
- 229940063675 spermine Drugs 0.000 description 3
- 235000004936 Bromus mango Nutrition 0.000 description 2
- 235000016623 Fragaria vesca Nutrition 0.000 description 2
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 240000007228 Mangifera indica Species 0.000 description 2
- 235000014826 Mangifera indica Nutrition 0.000 description 2
- 235000009184 Spondias indica Nutrition 0.000 description 2
- 244000228451 Stevia rebaudiana Species 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 238000005054 agglomeration Methods 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 235000015165 citric acid Nutrition 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 235000013409 condiments Nutrition 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- 239000011888 foil Substances 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 2
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 2
- PFNFFQXMRSDOHW-UHFFFAOYSA-N spermine Chemical compound NCCCNCCCCNCCCN PFNFFQXMRSDOHW-UHFFFAOYSA-N 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000001052 yellow pigment Substances 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 241000192700 Cyanobacteria Species 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 244000307700 Fragaria vesca Species 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 125000002059 L-arginyl group Chemical group O=C([*])[C@](N([H])[H])([H])C([H])([H])C([H])([H])C([H])([H])N([H])C(=N[H])N([H])[H] 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 206010027423 Metabolic alkalosis Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 108010077895 Sarcosine Proteins 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- YGCFIWIQZPHFLU-UHFFFAOYSA-N acesulfame Chemical compound CC1=CC(=O)NS(=O)(=O)O1 YGCFIWIQZPHFLU-UHFFFAOYSA-N 0.000 description 1
- 229960005164 acesulfame Drugs 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 description 1
- PMKLVGOZGNPKLG-UHFFFAOYSA-H dialuminum;2',4',5',7'-tetraiodo-3-oxospiro[2-benzofuran-1,9'-xanthene]-3',6'-diolate Chemical compound [Al+3].[Al+3].O1C(=O)C2=CC=CC=C2C21C1=CC(I)=C([O-])C(I)=C1OC1=C(I)C([O-])=C(I)C=C21.O1C(=O)C2=CC=CC=C2C21C1=CC(I)=C([O-])C(I)=C1OC1=C(I)C([O-])=C(I)C=C21.O1C(=O)C2=CC=CC=C2C21C1=CC(I)=C([O-])C(I)=C1OC1=C(I)C([O-])=C(I)C=C21 PMKLVGOZGNPKLG-UHFFFAOYSA-H 0.000 description 1
- 230000003205 diastolic effect Effects 0.000 description 1
- 210000003989 endothelium vascular Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- IINNWAYUJNWZRM-UHFFFAOYSA-L erythrosin B Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=C(I)C(=O)C(I)=C2OC2=C(I)C([O-])=C(I)C=C21 IINNWAYUJNWZRM-UHFFFAOYSA-L 0.000 description 1
- 239000004174 erythrosine Substances 0.000 description 1
- 235000012732 erythrosine Nutrition 0.000 description 1
- 229940011411 erythrosine Drugs 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 229940049920 malate Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000001053 orange pigment Substances 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 229940043230 sarcosine Drugs 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000019614 sour taste Nutrition 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 235000010215 titanium dioxide Nutrition 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Seasonings (AREA)
Abstract
Description
1245605 (1) 玖、發明說明 【發明所屬之技術領域】 本發明是有關一種含有L_精胺酸之營養補充產品的_ 造方法,尤其是利用乙醇藉濕式造粒法製造含有精胺酉变 之營養補充產品的方法。 〔發明背景〕 L-精胺酸(L-Arginine )是人體條件性需要的胺_ 酸’科學家在十九世紀末第一次從動物犀角分離出純的L-精胺酸,後來的硏究發現L-精胺酸是身體肌胺酸 (creatinine )的唯一來源,而肌胺酸是 ATP再生所必須 的物質。L-精胺酸也能增加血糖激素及胰島素的釋放,調 解血糖異常;此外,L-精胺酸曾成功地用來改善男性精蟲 生成及治療代謝性鹼中毒。 梅里(Ferid Murad )、富斯葛(Robert F. Furchgott)及伊格納羅(Louis J. Ignarro)等三位科學家 因發現一氧化氮(NO )是人體內無所不在傳遞訊號的重要 物質,而於1 998年獲得諾貝爾生醫獎。NO是一種生理性 氣體,由細胞產生後穿透細胞膜,進而調節細胞的功能。 L-精胺酸是一種氮含量豐富的胺基酸,比其他胺基酸的氮 含量多一倍,是一種極重要的N 0生理性前驅物,L -精胺 酸經由NO合成酶催化後產生NO,NO代表了血管內壁之 舒張因子,調節整個心血管的舒張彈性,以確保全身氧氣 充分供應,同時調整血管內皮之功能,防止脂類、血小 -4- (2) 1245605 板、白血球等之黏附,保持血管管腔之血流通暢無阻。 L-精胺酸可在蛋白質含量高的食品中發現,一般健康 人自身每日可製造足夠的L-精胺酸,可是在某些情況下, 必須由額外的方式供應,以維持身體的正常功能。 【先前技術】 本發明是有關含有L-精胺酸之營養補充產品的製造方 法,該營養補充產品的主要成分爲L-精胺酸,其他佐料可 爲酸味劑、甜味劑、香料、色素、及/或潤滑劑等。現存 以L-精胺酸爲主成分之粉狀營養補充產品在製造上是以粉 末直接混合或以水或水溶液進行濕式造粒兩種不同的方式 製造,然而這兩種製造方式均有其缺點或困難之處。 粉末直接混合的做法是將各成分直接混合,但要使用 此種方式,則各成分粉末必須符合多項高度要求,包括: 各成分粉末必須大小均勻,則混合後各成份的均勻度才會 好;粉末的密度高,如此在混合後產品才不會蓬鬆,且充 塡時不會飛揚;粉末的流動性要好,則裝袋的速度才會 快。然而各成分粉末難以充分達到這些要求,因而有改以 濕法造粒的方式來製造,亦即透過添加液體與濕粒的形成 來製造。此外,以粉末直接混合的方式製造時,還有充塡 包裝上的困擾,原因在於該營養補充產品具有吸濕性,以 鋁箔包裝爲例,將各成分粉末之混合物以粉末充塡時,會 有飛揚現象,飛揚後多少會有部份粉末沾到鋁箔袋邊緣, 使得封袋無法密合,而於儲存時產生吸濕結塊的現象。至 -5- (3) 1245605 於利用水或水溶液進行濕式造粒以製造該產品時,由於該 產品成分吸濕性強,吸濕後的產品黏性高,以水或水溶液 進行濕法造粒過程中由於黏性高而使製程難以順利進行。 【發明內容】 爲解決上述各項問題’本發明人經過硏究後發現,利 用乙醇或乙醇溶液進行濕法造粒以製造該營養補充產品 時,造粒過程極爲順利,免除了上述粉末直接混合製法有 關各成分粉末的多種特性需求與缺點,也改善了以水或水 溶液進行濕法造粒時所面臨黏性高以致影響操作的問題。 因此,本發明提供一種用於製造含有L-精胺酸之營養 補充產品之方法,包括: (a) 將L-精胺酸、至少一種選自酸味劑、甜味劑、色 素、塡充劑、香料及潤滑劑之佐料、及選擇性使 用之L-精胺酸以外之營養補充物質等用於製造該 產品之所有成分的全部或部份與乙醇以任何順序 加以混合並進行濕法造粒; (b) 將所得濕粒加以乾燥; (c) 選擇性將步驟(b)之乾燥顆粒加以整粒;及 (d) 當步驟(a)中參與混合的成分係用於製造該產品之 所有成分的部份時,將其餘成分加入後進行混 合。 本發明方法除了免除乾粉直接混合法的問題、改善水 濕式造粒法黏性高不易操作的缺點之外,還賦予多項優 -6- (4) 1245605 點,例如:不會有水濕式造粒法形成麵團狀的現象發生、 乾燥時間較短、乾燥溫度較低、產品不易結塊、顆粒均 勻、總表面積較小(即顆粒較大)、色素平均分布於顆粒 故接受度局、產品流動性佳、容易充塡包裝、產品入水後 的溶解速度快等等。此外,由於使用乙醇,因此在製造過 程中有額外的殺菌效果。 【實施方式】 本發明之營養補充產品中,係以L-精胺酸爲主成分, 其用量並無特殊限制,以該產品成分之總量計可爲約3 0 至約8 0重量%。 本發明之營養補充產品係顆粒之混合物,使用前可將 其加入水中後飮用。由於L-精胺酸是一種胺基酸,具有魚 腥味,單獨飮用L-精胺酸之溶液時會留有不悅感,因此未 添加調味劑之產品不易被消費者所接受。可用於調味之物 質如酸味劑、甜味劑、及香料等。 本發明所用之酸味劑可爲食品或製藥工業上常用者, 例如檸檬酸、蘋果酸等,其用量並無特殊限制,以能夠產 生適於口感之酸味即可,但足量的酸味劑可去除前述胺基 酸魚腥味之不悅感。 使用甜味劑可進一步增加消費者的接受度,本發明所 用之甜味劑可爲食品或製藥工業上常用者,例如阿斯巴甜 ( aspartame ) 、 Acesulfame K 甘草苹 (glycyrrhizine)、甜菊精(Stevia)、蔗糖等。其用量以 (5) 1245605 能夠產生適於口感之甜味即可。 本發明所用之香料可爲食品或製藥工業上常用者,例 如具有水果味之香料。 本發明所用之色素可爲食品或製藥工業上常用者,其 顏色的選擇可f合配香料使用,例如使用橘味香料時,可搭 配使用橘色色素。 用於本發明產品之成分亦可包括潤滑劑,其可爲食品 或製藥工業上常用者,例如二氧化矽、硬脂酸鎂、二氧化 鈦等。 用於本發明產品之成分亦可包含塡充劑,其可爲食品 或製藥工業上常用者,例如木糖醇(Xylit〇l )、乳糖 (lactose)、甘露糖醇(mannitol)、聚乙二醇 (polyethylene glycol)等。有些消費者可能不喜歡酸味 劑的酸味,此時可減量使用酸味劑,並以塡充劑取代之。 用於本發明產品之成分亦可包括L-精胺酸以外的其他 營養補充產品,例如甘蔗原素(ρ ο 1 i c 〇 s a η ο 1 )、蕃茄紅素 (lycopene)、紅麴、藍藻、麥苗粉等。 本案所用酸味劑、甜味劑、色素、香料、潤滑劑、塡 充劑等各佐料的用量並無特殊限制,其用量爲食品或製藥 領域之人士能夠判斷者,可視需要調整。 本發明用於製造含有L-精胺酸之營養補充產品的方法 包括下列步驟: (a)將L-精胺酸、至少一種選自酸味劑、甜味劑、色 素、塡充劑、香料及潤滑劑之佐料、及選擇性使 -8 - (6) 1245605 用之L-精胺酸以外之營養補充物質等用於製造該 產品之所有成分的全部或部份與乙醇以任何順序 加以混合並進行濕法造粒; (b) 將所得濕粒加以乾燥; (c) 選擇性將步驟(b)之乾燥顆粒加以整粒;及 (d) 當步驟(a)中參與混合的成分係用於製造該產品之 所有成分的部份時,將其餘成分加入後進行混 本發明方法中各成分的添加順序並無特殊限制,不過 潤滑劑與香料以在乾燥及整粒之後加入爲較佳,原因在於 潤滑劑是微粒介質,其緩衝於顆粒間、減少顆粒之間的摩 擦,並增加顆粒的流動性以利於充塡。至於香料,其一般 具有揮發性,爲避免其於乾燥或整粒過程中可能被揮發 掉,因此宜在乾燥與整粒等步驟之後才添加。此外,爲使 乙醇能夠均勻分布在成分顆粒上,乙醇的添加時機宜在L-精胺酸、酸味劑、甜味劑、色素、塡充劑混合之後;或 者,在L-精胺酸、酸味劑、甜味劑、塡充劑混合之後,再 於該混合物中把由色素溶在乙醇中所形成的乙醇溶液加 入。各成分在進行混合之前,可先經過硏磨與過篩的步 驟。 在步驟(a)中,乙醇的用量以所用成分總量每1 〇〇重量 份計係爲約3至約3 〇重量份,以約6至約1 5重量份爲較 佳。使用的乙醇可一次全部加入,亦可分數次加入;乙醇 可單獨加入或在溶解色素之後再加入。步驟(a)之混合與造 (8) 12456051245605 (1) 发明 Description of the invention [Technical field to which the invention belongs] The present invention relates to a method for manufacturing a nutritional supplement product containing L-spermine acid, in particular to use ethanol to make spermine-containing 酉 by wet granulation method Change to nutritional supplements. [Background of the Invention] L-Arginine is an amine acid required by the human condition. Scientists first isolated pure L-arginine from animal rhino horns at the end of the 19th century. L-arginine is the sole source of creatinine in the body, and sarcosine is a substance necessary for ATP regeneration. L-arginine can also increase the release of blood glucose hormones and insulin, and mediate abnormal blood glucose. In addition, L-arginine has been successfully used to improve male sperm production and treat metabolic alkalosis. Three scientists, including Ferid Murad, Robert F. Furchgott, and Louis J. Ignarro, discovered that nitric oxide (NO) is an important substance that transmits signals everywhere in the human body. In 998, he won the Nobel Prize in Biomedicine. NO is a physiological gas that is produced by cells and penetrates cell membranes to regulate cell functions. L-Arginine is a nitrogen-rich amino acid that has twice the nitrogen content of other amino acids. It is a very important physiological precursor of N 0. L-Arginine is catalyzed by NO synthetase. Generates NO, which represents a relaxing factor on the inner wall of blood vessels, which regulates the diastolic elasticity of the entire cardiovascular system to ensure adequate supply of oxygen throughout the body, while adjusting the function of the vascular endothelium, and preventing lipids and blood. The adhesion of white blood cells, etc., keeps the blood flow in the blood vessel lumen unobstructed. L-Arginine can be found in foods with high protein content. Generally, healthy people can make enough L-Arginine daily. However, in some cases, it must be supplied in additional ways to maintain the normal body. Features. [Previous technology] The present invention relates to a method for manufacturing a nutritional supplement product containing L-arginine. The main component of the nutritional supplement product is L-arginine. Other condiments can be acidulants, sweeteners, spices, Pigments and / or lubricants. Existing L-arginine-based powdered nutritional supplement products are manufactured by mixing powder directly or wet granulating with water or aqueous solution. However, both of these manufacturing methods have their own advantages. Weaknesses or difficulties. The method of direct powder mixing is to directly mix the ingredients, but to use this method, each ingredient powder must meet a number of height requirements, including: Each ingredient powder must be uniform in size, then the uniformity of the ingredients will be good after mixing; The density of the powder is high, so that the product will not be fluffy after being mixed, and will not fly when filled; if the powder has good fluidity, the bagging speed will be fast. However, it is difficult for each component powder to fully meet these requirements. Therefore, it has been manufactured by wet granulation, that is, by adding liquid and wet granules. In addition, when the powder is directly mixed, there is also a problem in filling and packaging. The reason is that the nutritional supplement product is hygroscopic. Taking aluminum foil packaging as an example, when the powder mixture of various ingredients is filled with powder, There is a flying phenomenon. After flying, some powder will stick to the edge of the aluminum foil bag, making the sealing bag unable to be tightly sealed, and the phenomenon of moisture absorption and agglomeration during storage. To -5- (3) 1245605 When using water or aqueous solution for wet granulation to manufacture this product, the product has strong hygroscopicity and high viscosity after absorbing moisture. Wet manufacturing with water or aqueous solution Due to the high viscosity in the granulation process, it is difficult to carry out the process smoothly. [Summary of the Invention] In order to solve the above-mentioned problems, the inventors found after research that when granulating with ethanol or an ethanol solution to produce the nutritional supplement product, the granulation process is extremely smooth, eliminating the need to directly mix the powder The manufacturing method is related to the various characteristic requirements and disadvantages of each component powder, and it also improves the problem of high viscosity that affects operation when wet granulation is performed with water or aqueous solution. Therefore, the present invention provides a method for manufacturing a nutritional supplement product containing L-arginine, comprising: (a) L-arginine, at least one selected from the group consisting of an acidulant, a sweetener, a pigment, and a tincture , Spices and lubricants, and supplementary substances other than L-arginine, which are used selectively, all or part of all ingredients used in the manufacture of this product are mixed with ethanol in any order and wet-processed Granules; (b) drying the obtained wet granules; (c) selectively granulating the dried granules of step (b); and (d) when the ingredients involved in the mixing in step (a) are used to manufacture the product For all ingredients, add the remaining ingredients and mix. In addition to avoiding the problem of direct mixing of dry powder and improving the disadvantages of water-wet granulation, which is difficult to operate, the method of the present invention also gives a number of excellent -6- (4) 1245605 points, such as: no water-wet method The dough-like phenomenon of the granulation method occurs, the drying time is short, the drying temperature is low, the product is not easy to agglomerate, the particles are uniform, the total surface area is small (that is, the particles are larger), the pigment is evenly distributed on the particles, so the acceptance of the product, Good fluidity, easy filling and packaging, fast dissolving speed when the product is in water, etc. In addition, the use of ethanol has an additional bactericidal effect during the manufacturing process. [Embodiment] The nutritional supplement product of the present invention is mainly composed of L-arginine, and its amount is not particularly limited, and may be about 30 to about 80% by weight based on the total amount of the product ingredients. The nutritional supplement product of the present invention is a mixture of granules, which can be used after being added to water before use. Since L-arginine is an amino acid with a fishy smell, it will leave an unpleasant feeling when the L-arginine solution is used alone. Therefore, products without added flavoring agents are not easily accepted by consumers. It can be used for flavoring substances such as sour, sweetener, and flavor. The sour agent used in the present invention may be one commonly used in the food or pharmaceutical industry, such as citric acid, malic acid, etc., and the amount thereof is not particularly limited so as to be able to produce a sour taste suitable for mouthfeel, but a sufficient amount of the sour agent can be removed The unpleasant fishy smell of the aforementioned amino acid. The use of sweeteners can further increase consumer acceptance. The sweeteners used in the present invention can be those commonly used in the food or pharmaceutical industry, such as aspartame, Acesulfame K glycyrrhizine, stevia ( Stevia), sucrose, etc. It can be used in an amount of (5) 1245605 to produce a sweetness suitable for mouthfeel. The flavors used in the present invention may be those commonly used in the food or pharmaceutical industry, such as fruity flavors. The pigments used in the present invention may be those commonly used in the food or pharmaceutical industry. The choice of color can be used in combination with spices. For example, when orange flavor is used, orange pigment can be used in combination. The ingredients used in the products of the present invention may also include lubricants, which may be those commonly used in the food or pharmaceutical industries, such as silicon dioxide, magnesium stearate, titanium dioxide, and the like. The ingredients used in the products of the present invention may also contain tinctures, which may be those commonly used in the food or pharmaceutical industries, such as Xylitol, lactose, mannitol, polyethylene Alcohol (polyethylene glycol), etc. Some consumers may not like the sourness of sour agents. In this case, they can reduce the amount of sour agents and replace them with tinctures. The ingredients used in the products of the present invention may also include other nutritional supplement products other than L-arginine, such as sugarcane (ρ ο 1 ic 〇sa η ο 1), lycopene, red tincture, cyanobacteria, Wheat seed powder and so on. There are no particular restrictions on the amount of each condiment used in this case, such as sour agents, sweeteners, pigments, flavors, lubricants, and fillers, and the amounts are those that can be judged by those in the food or pharmaceutical fields and can be adjusted as needed. The method for producing a nutritional supplement product containing L-arginine according to the present invention includes the following steps: (a) selecting L-arginine, at least one selected from the group consisting of an acidulant, a sweetener, a colorant, a tincture, a flavor, and Additives for lubricants, and optionally make use of -8-(6) 1245605 nutritional supplements other than L-arginine, etc. All or part of all ingredients used to make this product are mixed with ethanol in any order And wet granulation; (b) drying the obtained wet granules; (c) selectively granulating the dried granules of step (b); and (d) when the ingredients involved in mixing in step (a) are used When manufacturing all the ingredients of the product, there is no particular limitation on the order of adding the ingredients in the method of the present invention after the rest of the ingredients are added, but it is better to add the lubricant and fragrance after drying and granulating. The reason is that the lubricant is a particulate medium, which buffers between particles, reduces friction between particles, and increases the fluidity of particles to facilitate filling. As for the fragrance, it is generally volatile. In order to prevent it from being volatilized during the drying or granulation process, it should be added after the drying and granulation steps. In addition, in order to allow the ethanol to be evenly distributed on the component particles, the timing of the addition of ethanol should be after mixing L-spermine, sour, sweetener, pigment, tincture; or, after L-sperine, sour After the agent, sweetener and tincture are mixed, an ethanol solution formed by dissolving the pigment in ethanol is added to the mixture. The ingredients can be honed and sieved before they are mixed. In step (a), the amount of ethanol used is about 3 to about 30 parts by weight, and preferably about 6 to about 15 parts by weight based on the total amount of ingredients used. The ethanol used can be added all at once or in several times; ethanol can be added separately or after dissolving the pigment. Mixing and making in step (a) (8) 1245605
Sunset Yellow等成分依表1所列示之用量加入Supermixer 中先行混合,再將L -精胺酸加入該 S u p e r m i X e r裡混合。 在所得混合物中添加乙醇(90公克)之後,實施濕法造 粒。把濕法造粒所產生的濕粒置於6〇 °C之烘箱中乾燥2小 時、並以F i t z m i 11過2 0號篩進行整粒後,添加C a b - 0 - S i 1 與橘味香料,再以V-blender加以混合後進行包裝。 表1 成分 功能 重量百分比 1公斤批量 L-精胺酸 主成分 6 4.94% 0.6494公斤 蘋果酸 酸味劑 2 6.00% 0.2600公斤 檸檬酸 酸味劑 6.50% 0.0650公斤 阿斯巴甜 甜味劑 0.60% 0.0060公斤 Acesulfame K 甜味劑 0.40% 0.0 0 4 0公斤 Sunset Yellow 色素 0.06% 0.0006公斤 橘味香料 香料 0.60% 0.0060公斤 Cab-O-Sil 潤滑劑 0.90% 0.0090公斤 比較例1 將蘋果酸、檸檬酸、阿斯巴甜及Acesulfame K等成 分依表1所列示之用量加入Supermixer中先行混合,再將 L-精胺酸加入該 Supermixer裡混合。將色素 Sunset Yellow溶於水(30公克)後,把該色素水溶液加入該混 合物之後進行濕法造粒。產生的濕粒在6 0 °C之烘箱中乾 燥 3小時、並以Fitzmill過20號篩進行整粒後,添加 -11 - 1245605 Ο)Ingredients such as Sunset Yellow are added to the Supermixer in the amounts listed in Table 1 and mixed first, and then L-arginine is added to the Supper r m i X e r and mixed. After ethanol (90 g) was added to the obtained mixture, wet granulation was performed. The wet granules produced by the wet granulation were dried in an oven at 60 ° C for 2 hours, and then granulated with a Fitzmi 11 through a No. 20 sieve. Then, C ab-0-S i 1 and orange flavor were added. The spices are mixed with V-blender and packaged. Table 1 Ingredient Function Weight Percent 1 kg Batch L-Arginine Main Ingredients 6 4.94% 0.6494 kg Malate Sour Flavor 2 6.00% 0.2600 kg Citric Sour Flavor 6.50% 0.0650 kg Aspartame Sweet Sweetener 0.60% 0.0060 kg Acesulfame K Sweetener 0.40% 0.0 0 4 0 kg Sunset Yellow Pigment 0.06% 0.0006 kg Orange Flavor Spice 0.60% 0.0060 kg Cab-O-Sil Lubricant 0.90% 0.0090 kg Comparative Example 1 Malic acid, citric acid, aspar Ingredients such as sweet and Acesulfame K are added to the Supermixer in the amounts listed in Table 1 and mixed first, and then L-Arginine is added to the Supermixer and mixed. After the pigment Sunset Yellow was dissolved in water (30 g), the pigment aqueous solution was added to the mixture, followed by wet granulation. The generated wet granules are dried in an oven at 60 ° C for 3 hours, and granulated through a No. 20 sieve in a Fitzmill, then added -11-1245605 Ο)
Cab-0-Sil與橘味香料’再以V-blender加以混合後進行包 裝。 以下就實施例1與比較例1之製造過程與產品加以'比 較,詳如下表A。Cab-0-Sil and orange flavor 'are mixed with V-blender and packaged. The following compares the manufacturing process and products of Example 1 and Comparative Example 1, as shown in Table A below.
-12- (10) 1245605 結塊 殘存水量較高時,在儲 存情況下,產品易結 塊。 成份對乙醇的親合性 不高,在殘存乙醇情 況下,產品也不易結 塊。 殺菌 造粒過程中沒有額外殺 菌的作用。 由於乙醇的處理,造 粒過程中有額外殺菌 的效果。-12- (10) 1245605 Agglomeration When the amount of residual water is high, the product tends to agglomerate under storage conditions. The affinity of the ingredients for ethanol is not high, and in the case of residual ethanol, the product is not easy to agglomerate. Sterilization There is no additional bactericidal effect during the granulation process. Due to the ethanol treatment, there is an additional bactericidal effect during the granulation process.
實施例2Example 2
將蘋果酸、檸檬酸、木糖醇、阿斯巴甜、Acesulfame K以及色素Erythrosine Aluminum Lake等成分依下表2所 列示之用量加入Supermixer中先行混合,再將L-精胺酸 加入該S u p e r m i X e r裡混合。在所得混合物中添加乙醇(9 0 公克)之後,實施濕法造粒。把濕法造粒所產生的濕粒置 於60°C之烘箱中乾燥2小時 '並以Fitzmill過20號篩進 行整粒後,添加Cab-0-Sil與草莓味香料,再以V-blender 加以混合後進行包裝。 -13- (11) 1245605 表2 成分 功能 重量百分比 1公斤批量 L-精胺酸 主成分 6 4.94% 0.6494公斤 蘋果酸 酸味劑 13.00% 0 . 1 3 0 0公斤 檸檬酸 酸味劑 3.25% 0.0325公斤 木糖醇 塡充劑 16.07% 0. 1 607公斤 阿斯巴甜 甜味劑 0.60% 0.0060公斤 Acesulfame K 甜味劑 0.40% 0.0040公斤 Erythro sine 色素 0.04% 0.0004公斤 Aluminum Lake 草苺味香料 香料 0.80% 0.0080公斤 Cab-O-Sil 潤滑劑 0.90% 0.0090公斤Add malic acid, citric acid, xylitol, aspartame, Acesulfame K, and pigment Erythrosine Aluminum Lake to the Supermixer in the amounts listed in Table 2 below, mix them first, and then add L-Arginine to the S upermi X er mixed. After adding ethanol (90 g) to the obtained mixture, wet granulation was performed. The wet granules produced by wet granulation are dried in an oven at 60 ° C for 2 hours, and then granulated through a No. 20 sieve in a Fitzmill. Then add Cab-0-Sil and strawberry flavor spices, and then use V-blender Mix and package. -13- (11) 1245605 Table 2 Ingredient Function Weight Percent 1kg Bulk L-Arginine Main Ingredients 6 4.94% 0.6494 kg Malic Acid Sour Agent 13.00% 0. 1 3 0 0 kg Citric Acid Sour Agent 3.25% 0.0325 kg Wood Sugar alcohol tincture 16.07% 0.167 kg Aspartame sweetener 0.60% 0.0060 kg Acesulfame K sweetener 0.40% 0.0040 kg Erythro sine Pigment 0.04% 0.0004 kg Aluminum Lake Strawberry Flavor Spice 0.80% 0.0080 kg Cab -O-Sil lubricant 0.90% 0.0090 kg
實施例3Example 3
將蘋果酸、檸檬酸、木糖醇、阿斯巴甜、Acesulfame K以及色素Tartrazine Aluminum Lake等成分依下表3所 列不之用量加入 S u p e r m i X e r中先行混合,再將L -精胺酸 加入該Super mixer裡混合。在所得混合物中添加乙醇(90 公克)之後,實施濕法造粒。把濕法造粒所產生的濕粒置 於60°C之烘箱中乾燥2小時、並以Fitzmill過20號篩進 行整粒後,添加Cab-0-Sil與芒果味香料,再以V-blender 加以混合後進行包裝。 -14- (12) 1245605 表3 成分 功能 ------- 重量百分比 1公斤批量 L-精胺酸 主成分 6 4.94% 0 · 6 4 9 4公斤 蘋果酸 酸味劑 13.00% 0. 1 3 00公斤 檸檬酸 酸味劑 3.25% ___ 0.0325公斤 木糖醇 塡充劑 16.06% 0 . 1 6 0 6公斤 阿斯巴甜 甜味劑 0.60% 0.0060公斤 Acesulfame K 甜味劑 0.40% 0.0 0 4 0公斤 T artrazine 色素 0.05% 0.0005公斤 Aluminum Lake 芒果味香料 香料 0.80% 0.0080公斤 Cab-O-Sil 潤滑劑 0.90% 0.0090公斤 實施例4 將檸檬酸硏磨並過60號篩後(顆粒大小爲250 μ m ),把L -精胺酸、蘋果酸、硏磨過的檸檬酸、阿斯巴 甜及Acesulfame依下表4所列不之用里加入谷挤中進行 混合。將Sunset Yellow溶於乙醇中,接著在攪拌過程中 把前述Sunset Yellow的乙醇溶液慢慢加入該容器中的混 合物裡,於攪拌過程中,再將乙醇分二至三次加入前述所 得混合物裡(合計乙醇總用量爲90公克),進行濕法造 粒。把得到的混合濕粒置於乾燥箱中,於6 0 °C之乾燥溫 度下去除乙醇,再將去除乙醇後的乾粒過篩。過篩後的乾 粒倒入V-blender,再分別加入橘味香料與Cab-0-Sil進行 -15- (13) 1245605 混合後包裝。 表4Add malic acid, citric acid, xylitol, aspartame, Acesulfame K, and the pigment Tartarine Aluminum Lake to the Supermi X er in the amounts listed in Table 3 below, mix them first, and then add L-arginine Add this Super mixer and mix. After adding ethanol (90 g) to the obtained mixture, wet granulation was performed. The wet granules produced by the wet granulation are dried in an oven at 60 ° C for 2 hours, and the whole granules are passed through a No. 20 sieve in a Fitzmill. Then add Cab-0-Sil and mango flavor, and then use V-blender Mix and package. -14- (12) 1245605 Table 3 Ingredient function ------- weight percentage 1 kg batch L-arginine main ingredient 6 4.94% 0 · 6 4 9 4 kg malic acid flavoring agent 13.00% 0. 1 3 00 kg citric acid sour agent 3.25% ___ 0.0325 kg xylitol tincture 16.06% 0. 1 6 0 6 kg aspartame sweetener 0.60% 0.0060 kg Acesulfame K sweetener 0.40% 0.0 0 4 0 kg T artrazine Pigment 0.05% 0.0005 kg Aluminum Lake Mango Flavor Spice 0.80% 0.0080 kg Cab-O-Sil Lubricant 0.90% 0.0090 kg Example 4 After citric acid honing and passing through a No. 60 sieve (particle size 250 μm), Add L-arginine, malic acid, milled citric acid, aspartame, and Acesulfame to the squeeze as shown in Table 4 below and mix. Dissolve Sunset Yellow in ethanol, and then slowly add the aforementioned ethanol solution of Sunset Yellow to the mixture in the container during the stirring process. During the stirring process, add two to three times of ethanol to the obtained mixture (total ethanol) The total amount is 90 g), and wet granulation is performed. The obtained mixed wet granules were placed in a drying box, and the ethanol was removed at a drying temperature of 60 ° C, and then the dry granules after removing the ethanol were sieved. The sieved dry granules are poured into V-blender, and orange flavor is added separately with Cab-0-Sil for -15- (13) 1245605 and packaged. Table 4
成分 功能 重量百分比 1公斤批量 L-精胺酸 主成分 6 4.94% 0.6 4 9 4公斤 蘋果酸 酸味劑 2 6.00% 0.2600公斤 檸檬酸 酸味劑 6.50% 0.0650公斤 阿斯巴甜 甜味劑 0.60% 0.0060公斤 Acesulfame K 甜味劑 0.40% 0.0040公斤 Sunset Yellow 色素 0.06% 0.0006公斤 橘味香料 香料 0.60% 0.0060公斤 Cab-O-Sil 潤滑劑 0.90% 0.0090公斤Ingredient Function Weight Percent 1kg Bulk L-Arginine Main Ingredients 6 4.94% 0.6 4 9 4 kg Malic Acid Sour Agent 2 6.00% 0.2600 kg Citric Acid Sour Agent 6.50% 0.0650 kg Aspartame Sweet Sweetener 0.60% 0.0060 kg Acesulfame K 0.40% 0.0040 kg Sunset Yellow Pigment 0.06% 0.0006 kg Orange Flavor Spice 0.60% 0.0060 kg Cab-O-Sil Lubricant 0.90% 0.0090 kg
-16--16-
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW92115715A TWI245605B (en) | 2003-06-10 | 2003-06-10 | Method for producing nutritional product containing L-Arginine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW92115715A TWI245605B (en) | 2003-06-10 | 2003-06-10 | Method for producing nutritional product containing L-Arginine |
Publications (2)
Publication Number | Publication Date |
---|---|
TW200427414A TW200427414A (en) | 2004-12-16 |
TWI245605B true TWI245605B (en) | 2005-12-21 |
Family
ID=37191150
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW92115715A TWI245605B (en) | 2003-06-10 | 2003-06-10 | Method for producing nutritional product containing L-Arginine |
Country Status (1)
Country | Link |
---|---|
TW (1) | TWI245605B (en) |
-
2003
- 2003-06-10 TW TW92115715A patent/TWI245605B/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
TW200427414A (en) | 2004-12-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1164873B1 (en) | Production of highly soluble and stable mineral supplements | |
TWI351925B (en) | Composition comprising coenzyme q10 | |
WO2018077310A1 (en) | Vitamin c sodium-containing effervescent tablet and preparation method therefor | |
JP2013532476A (en) | Vegetable and fruit powder | |
CN101282721A (en) | Composition for improving subjective symptoms of fatigue | |
US20060280843A1 (en) | Filler for a beverage container | |
Kothakota et al. | Characteristics of spray dried dahi powder with maltodextrin as an adjunct | |
TWI245605B (en) | Method for producing nutritional product containing L-Arginine | |
JP5582033B2 (en) | Oral preparation containing branched chain amino acids | |
JP2015514119A (en) | Wet granulation method and granular material containing gum arabic | |
JP2014103872A (en) | Jelling composition | |
CN109259246A (en) | Particle nutritional supplement of calcic and preparation method thereof | |
WO2019053747A1 (en) | Process and formulation of powdered sweet lime fruit juice with enhanced real fruit content and stability | |
JP2017036329A (en) | Jelly containing branched chain amino acids | |
JP4588403B2 (en) | Method for producing calcium / magnesium-containing composition | |
KR101784462B1 (en) | Sweetening composition with regular ratio of components and preparation method thereof | |
JP6398181B2 (en) | Ubiquinol-rich gel composition | |
CN102573503A (en) | Flavanones-containing food compositions | |
JP2009232829A (en) | Favorite food | |
Antora | Overcoming the Bitter Taste of Iodine in Fortified Foods Using Encapsulation Techniques | |
Akter Antora | Overcoming the bitter taste of iodine in fortified foods using encapsulation technique | |
CN118575885A (en) | A method for preparing compressed candy | |
JP2025035373A (en) | A dietary supplement consisting of individual packets of baking soda and citric acid | |
CN116671589A (en) | A direct drinking powder containing polyunsaturated fatty acid | |
CN119866182A (en) | Powder composition, combination food for masking bitterness of medicament, method of masking bitterness of medicament, use of powder composition and method of use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Annulment or lapse of patent due to non-payment of fees |